Candida albicans: presence, function and treatments

Candida albicans: presence, function and treatments

Candida albicans is a fungus usually found in the flora of the mucous membranes. It is not pathogenic and contributes to the balance of our microbiota. However, an anarchic proliferation of this yeast is pathological: it is called candidiasis.

Candida albicans, what is it?

Candida albicans is a yeast-like fungus of the genus Candida and of the saccharomycetaceae family. Candida albicans is classified among the asexual fungi whose reproduction is predominantly clonal. Candida albicans is a diploid organism that has 8 pairs of chromosomes. Its heterozygosity gives it a great ability to adapt to various environments.

Candida albicans is naturally constitutive of the flora of the mucous membrane of the human being. Its presence is not pathological. We find this fungus in the digestive tract of 70% of healthy adults. However, a hormonal or immune imbalance can be responsible for an anarchic multiplication of this fungus which then causes certain symptoms. We are talking about candidiasis or even mycosis.

C. albicans virulence factors allow it to proliferate:

  • dimorphism (transformation of yeast to fungus depending on the surrounding environment);
  • adhesins (large number of surface receptors allowing C. albicans to easily adhere to the cells of its host);
  • enzymatic secretions;
  • etc.

C. albicans infections can be localized to the genital, oral or digestive mucosa. In addition, the overgrowth of Candida albicans on the skin is abnormal and causes skin signs. More rarely, in immunocompromised patients, C. albicans can colonize one or more organs or even the entire body: we speak of systemic candidiasis. In this case, the risk of death is around 40%.

Candida albicans: role and location

Candida albicans is a microorganism commensal to the microbial flora in humans and warm-blooded animals. It is present in the oral, digestive and genital mucous membranes, in the form of blastospores, considered to be the saprophytic form which lives in symbiosis with the host organism. In healthy subjects, the yeast is distributed differently depending on the sampling sites, the main reservoir remains the digestive tract:

  • skin (3%);
  • vagina (13%);
  • tract ano-rectal (15%);
  • oral cavity (18%);
  • stomach and duodenum (36%);
  • jejunum and ileum (41%).

However, these figures should be observed with caution insofar as the sampling techniques are not always identical and the sampling sites do not always present a homogeneous environment.

C.albicans is therefore necessary for the balance of the microbiota. However, when this balance in its commensal form and the immune defenses are broken, this symbiosis becomes parasitic. This results in an infectious disease called candidiasis.

What are the anomalies and pathologies caused by Candida albicans?

Candidiasis is a condition caused by the fungus Candida albicans. It is not a contagious disease: yeast is already present in the body, in the mucous membranes, mouth, digestive system and genitals. Candidiasis is linked to an anarchic proliferation of Candida albicans, itself caused by an immune or hormonal imbalance or a weakening of the microbial flora. In addition, genital yeast infections are not regarded as sexually transmitted infections (STIs), although sexual intercourse is a risk factor for yeast infections (the latter inducing a weakening of the genital flora).

However, human-to-human transmission of C. albicans is possible through contact with faeces, salivary secretions or through the hands. In hospitals, C. albicans represent the major cause of Nosocomial infections opportunistic.

Risk factors

Certain risk factors expose the development of candidiasis:

  • repeated courses of antibiotics;
  • taking treatments that impair immunity (corticosteroids, immunosuppressants, chemotherapy, etc.);
  • a immunodépression (of congenital origin, linked to HIV or to a transplant).

Vaginal yeast infections are the most frequent candidiasis, affecting 10 to 20% of women during sexual activity. They are favored by:

  • hormonal changes;
  • taking estrogen-progestogen contraceptives;
  • perspiration ;
  • pants that are too tight;
  • underwear that is not made of cotton (and especially thongs);
  • wearing panty liners;
  • poor hygiene;
  • prolonged sexual intercourse.

Candidiasis and their treatments

Candidiasis

Symptoms and diagnosis

Treatments

Cutaneous candidiasis

  • Rashes in the folds of the skin (armpits, breast folds, etc.);
  • Itchy, sometimes crusty red patches;
  • Diagnosis by clinical examination and more rarely by local sampling.
  • Local antifungal (imidazoles, polyenes, cyclopiroxolamine) for 2 to 4 weeks.
  • Systemic antifungal (fluconazole) in case of immunosuppression, resistance to treatment or relapse.

Candidiasis of the nails

  • Swelling of the fingers and detachment of the nails;
  • Diagnosis by clinical examination and more rarely by mycological sample of the nail.
  • Antifungal cream or film-forming solution (imidazoles, cyclopiroxolamine, amorolfine) until the nail grows back;
  • Excision of the nail;
  • Systemic antifungal (fluconazole) in case of immunosuppression, resistance to treatment or relapse.

Vaginal yeast infection

  • More abundant and smelly white discharge, severe itching, pain when urinating or having sex, etc. ;
  • Diagnosis by clinical examination or vaginal smear.
  • Azole antifungals: eggs, capsules, gel (butaconazole, econazole, miconazole, fenticonazole, etc.) for 3 days. The application of an azole cream can continue for 15 to 28 days. The use of an alkalizing soap adapted to the genital flora is recommended;
  • Systemic antifungal (fluconazole) in case of immunosuppression, resistance to treatment or relapse.

Oral thrush

  • Presence of a white deposit around the lips, on the tongue and the palate (infants and immunocompromised patients are particularly at risk);
  • Diagnosis by clinical and cytological examination.
  • Local antifungal (nystatin, amphetecerin B or AmB, miconazole, etc.) for 10 days to 3 weeks;
  • Systemic antifungal (fluconazole) in case of immunosuppression, resistance to treatment or relapse.

Digestive candidiasis

  • Abdominal pain, digestive disorders, bloating, gas, nausea, vomiting, etc. (immunocompromised patients are particularly at risk);
  • Diagnosis by clinical examination and stool analyzes.
  • Systemic antifungal treatment (fluconazole), up to 15 days in case of systemic candidiasis.

Systemic candidiasis

  • Weakening of the general condition, flu-like state, development of cutaneous, oral or genital mycoses (immunocompromised patients are particularly at risk);
  • Diagnosis by clinical examination and blood test (serology, blood culture).

Leave a Reply